Rhumbline Advisers decreased its position in The Joint Corp. (NASDAQ:JYNT – Free Report) by 4.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,447 shares of the company’s stock after selling 898 shares during the period. Rhumbline Advisers owned approximately 0.12% of Joint worth $259,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its stake in Joint by 5.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after purchasing an additional 837 shares in the last quarter. Avondale Wealth Management lifted its position in Joint by 192.3% in the 1st quarter. Avondale Wealth Management now owns 19,000 shares of the company’s stock valued at $248,000 after acquiring an additional 12,500 shares in the last quarter. Bridge City Capital LLC boosted its stake in Joint by 75.2% in the 1st quarter. Bridge City Capital LLC now owns 22,115 shares of the company’s stock worth $289,000 after purchasing an additional 9,492 shares during the period. Corsair Capital Management L.P. bought a new position in Joint during the 4th quarter worth about $248,000. Finally, Sierra Summit Advisors LLC acquired a new stake in shares of Joint in the 4th quarter valued at about $652,000. Institutional investors and hedge funds own 76.88% of the company’s stock.
Joint Stock Up 0.3 %
NASDAQ JYNT opened at $11.59 on Friday. The firm’s 50 day moving average is $11.94 and its 200-day moving average is $13.25. The company has a market capitalization of $173.55 million, a PE ratio of -15.45 and a beta of 1.58. The Joint Corp. has a 12-month low of $7.31 and a 12-month high of $17.82.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Recommended Stories
- Five stocks we like better than Joint
- Utilities Stocks Explained – How and Why to Invest in Utilities
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MarketBeat Week in Review – 9/23 – 9/27
- Stock Market Upgrades: What Are They?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.